Rainier Therapeutics Competitors and Similar CompaniesClear all
Rainier Therapeutics's competitors and similar companies include HUYA Bioscience International, Ascendis Pharma, Kyowa Kirin and Innovative Cellular Therapeutics.
 Rainier Therapeutics Rainier Therapeutics (formerly BioClin Therapeutics) is a biotechnology company developing targeted therapy for bladder cancer. |  HUYA Bioscience International HUYA Bioscience International is a company specializing in the biopharmaceutical products. |  Ascendis Pharma Ascendis Pharma is a biopharmaceutical company that specializes in endocrinology and oncology. |  Kyowa Kirin Kyowa Kirin (formerly Kyowa Hakko Kirin) is a pharmaceutical company focused on the areas of oncology, nephrology, immunology, and the central nervous system. |  Innovative Cellular Therapeutics Innovative Cellular Therapeutics (ICT, 斯丹赛生物技术) is a biotechnology company focused on the development of cellular immunotherapies for the treatment of cancer. | |
Founding Date | Founding Date 2010 | Founding Date 2004 | Founding Date 2007 | Founding Date 2008 | Founding Date 2009 |
Type | Type Private | Type Private | Type Public | Type Public | Type Private |
Tags | |||||
Locations | Locations San Ramon, US HQ | Locations San Diego, US HQ Chengdu Shi, CN Guangzhou Shi, CN Hangzhou, CN Shenzhen Shi, CN Shenzhen Shi, CN Suzhou Shi, CN see more | Locations Hellerup, DK HQ Heidelberg, DE Palo Alto, US | Locations Rockville, US HQ | |
Employees | Employees 1 | Employees 1113% increase | Employees 1,017 | Employees 5,669 | Employees 13 |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 7.7 b | Valuation ($) 8.8 b | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) €720.1m (FY, 2025) | Revenue (est.) ¥496.8b (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods €93.1m (FY, 2025) | Cost of goods ¥114.3b (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit €627.1m (FY, 2025) | Gross profit ¥383.4b (FY, 2025) | Gross profit N/A |
Net income | Net income N/A | Net income N/A | Net income (€228m) (FY, 2025) | Net income ¥67b (FY, 2025) | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round $ 30m (about 9 years ago) | Latest funding round $ 7.6m (over 14 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 28.3m (about 8 years ago) |
Total funding raised | Total funding raised $ 69m | Total funding raised $ 12.6m | Total funding raised $ 85.8m | Total funding raised N/A | Total funding raised $ 28.3m |
For sources of this data, please see the company profile
View Company Profiles
HUYA Bioscience International
HQ
San Diego, US
Employees
111↑ 3% increase
HUYA Bioscience International is a company specializing in the biopharmaceutical products.
View companyAscendis Pharma
HQ
Hellerup, DK
Employees
1,017
Ascendis Pharma is a biopharmaceutical company that specializes in endocrinology and oncology.
View companyKyowa Kirin
HQ
Tokyo, JP
Employees
5,669
Kyowa Kirin (formerly Kyowa Hakko Kirin) is a pharmaceutical company focused on the areas of oncology, nephrology, immunology, and the central nervous system.
View companyInnovative Cellular Therapeutics
HQ
Rockville, US
Employees
13
Innovative Cellular Therapeutics (ICT, 斯丹赛生物技术) is a biotechnology company focused on the development of cellular immunotherapies for the treatment of cancer.
View company